Subscribe To
Moderna stock crash steepens—but expert declares incoming flu vaccine results could show ‘superiority'
Moderna stock fell 4% despite the bullish projection, pushing shares down nearly 72% below their August all-time high....
February 23, 2022, 10:34 am
Moderna stock crash steepens—but expert declares incoming flu vaccine results could show ‘superiority'
Moderna stock fell 4% despite the bullish projection, pushing shares down nearly 72% below their August all-time high....
February 23, 2022, 10:34 am
Moderna and thermo fisher enter long-term agreement on large-scale manufacturing of covid vaccine
Moderna Inc. MRNA, -0.53% and life-sciences company Thermo Fisher Scientific Inc. TMO, -1.35% said Wednesday they have entered a long-term agreement t...
February 23, 2022, 8:36 am
Moderna and thermo fisher enter long-term agreement on large-scale manufacturing of covid vaccine
Moderna Inc. MRNA, -0.53% and life-sciences company Thermo Fisher Scientific Inc. TMO, -1.35% said Wednesday they have entered a long-term agreement t...
February 23, 2022, 8:36 am
Moderna and thermo fisher enter long-term agreement on large-scale manufacturing of covid vaccine
Moderna Inc. MRNA, -0.53% and life-sciences company Thermo Fisher Scientific Inc. TMO, -1.35% said Wednesday they have entered a long-term agreement t...
February 23, 2022, 8:36 am
Glaxosmithkline and sanofi plan to submit data from covid-19 booster and phase iii trials for approval
GlaxoSmithKline PLC (LSE:GSK) and Sanofi SA said they plan to submit data from their booster and Phase III trials as a basis for their regulatory appl...
February 23, 2022, 6:19 am
Glaxosmithkline and sanofi plan to submit data from covid-19 booster and phase iii trials for approval
GlaxoSmithKline PLC (LSE:GSK) and Sanofi SA said they plan to submit data from their booster and Phase III trials as a basis for their regulatory appl...
February 23, 2022, 6:19 am
Glaxosmithkline and sanofi plan to submit data from covid-19 booster and phase iii trials for approval
GlaxoSmithKline PLC (LSE:GSK) and Sanofi SA said they plan to submit data from their booster and Phase III trials as a basis for their regulatory appl...
February 23, 2022, 6:19 am
Dow jones newswires: sanofi, gsk to seek approval for covid-19 vaccine after positive trial results
Sanofi SA SNY, -0.80% and GlaxoSmithKline PLC GSK, -0.81% said Wednesday that their jointly-developed coronavirus v...
February 23, 2022, 6:19 am
Dow jones newswires: sanofi, gsk to seek approval for covid-19 vaccine after positive trial results
Sanofi SA SNY, -0.80% and GlaxoSmithKline PLC GSK, -0.81% said Wednesday that their jointly-developed coronavirus v...
February 23, 2022, 6:19 am
Dow jones newswires: sanofi, gsk to seek approval for covid-19 vaccine after positive trial results
Sanofi SA SNY, -0.80% and GlaxoSmithKline PLC GSK, -0.81% said Wednesday that their jointly-developed coronavirus v...
February 23, 2022, 6:19 am
Why ocugen stock is skyrocketing today
The FDA lifted a clinical hold that had been preventing Ocugen from starting a U.S.-based phase 3 clinical study of its COVID-19 v...
February 22, 2022, 12:15 pm
Why ocugen stock is skyrocketing today
The FDA lifted a clinical hold that had been preventing Ocugen from starting a U.S.-based phase 3 clinical study of its COVID-19 v...
February 22, 2022, 12:15 pm
Why ocugen stock is skyrocketing today
The FDA lifted a clinical hold that had been preventing Ocugen from starting a U.S.-based phase 3 clinical study of its COVID-19 v...
February 22, 2022, 12:15 pm
Moderna offers deep value as drug pipeline flows fast
MRNA stock has fallen into the buy zone, providing a prime opportunity as Moderna develops and commercializes multiple v...
February 22, 2022, 11:37 am
Moderna offers deep value as drug pipeline flows fast
MRNA stock has fallen into the buy zone, providing a prime opportunity as Moderna develops and commercializes multiple v...
February 22, 2022, 11:37 am
Moderna offers deep value as drug pipeline flows fast
MRNA stock has fallen into the buy zone, providing a prime opportunity as Moderna develops and commercializes multiple v...
February 22, 2022, 11:37 am
Moderna's stock gains 3% as it moves forward with phase 3 clinical trial for rsv vaccine candidate
Shares of Moderna Inc. MRNA, +2.82% gained 3.0% in trading on Monday after the company said it began a Phase 3 clinical trial evaluating its respirato...
February 22, 2022, 10:30 am
Moderna's stock gains 3% as it moves forward with phase 3 clinical trial for rsv vaccine candidate
Shares of Moderna Inc. MRNA, +2.82% gained 3.0% in trading on Monday after the company said it began a Phase 3 clinical trial evaluating its respirato...
February 22, 2022, 10:30 am
Moderna's stock gains 3% as it moves forward with phase 3 clinical trial for rsv vaccine candidate
Shares of Moderna Inc. MRNA, +2.82% gained 3.0% in trading on Monday after the company said it began a Phase 3 clinical trial evaluating its respirato...
February 22, 2022, 10:30 am